Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 606.00
+4.60 (0.76%)
Aug 11, 2025, 9:05 AM CET
Nevro Revenue
Coloplast had revenue of 6.93B DKK in the quarter ending March 31, 2025, with 5.22% growth. This brings the company's revenue in the last twelve months to 27.79B, up 8.89% year-over-year. In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B with 10.33% growth.
Revenue (ttm)
27.79B
Revenue Growth
+8.89%
P/S Ratio
4.87
Revenue / Employee
1.66M
Employees
16,639
Market Cap
135.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
| Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
| Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
| Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
| Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Genmab | 22.30B |
| Demant | 22.42B |
| ALK-Abelló | 5.71B |
| H. Lundbeck | 22.95B |
| Ambu A/S | 5.83B |
| Zealand Pharma | 55.69M |
| Bavarian Nordic | 6.23B |
Coloplast News
- 3 days ago - Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST - GlobeNewsWire
- 11 days ago - Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What's Fueling the Surge? | MarketsandMarkets™. - Benzinga
- 2 months ago - Coloplast: Finally Getting Buyable - Seeking Alpha
- 2 months ago - Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025 - GlobeNewsWire
- 3 months ago - Coloplast A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Coloplast A/S (CLPBF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons - GlobeNewsWire
- 3 months ago - Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25 - GlobeNewsWire